Stocks News

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Moderna Price Target Announced at $41.00/Share by B of A Securities, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: MRNA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  December 10, 2024 07:41 ET (12:41 GMT)
Dec 3, 2024
- DexCom, Orthofix, Spire Global, and Moderna Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 8:07AM ET on Tuesday Dec 03, 2024 by Dow Jones
  8:07AM ET on Tuesday Dec 03, 2024 by Dow Jones
  Companies Mentioned: DXCM, OFIX, MRNA, SPIR
  
  DexCom, Orthofix, Spire Global, and Moderna Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
  
  SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP investigates potential violations of federal and state laws by certain officers of several publicly traded companies, including DexCom, Inc. (DXCM), Spire Global, Inc. (NYSE: SPIR), Orthofix Medical Inc. (NASDAQ: OFIX), and Moderna, Inc. (NASDAQ: MRNA).
Nov 26, 2024
- DJ Moderna Is Maintained at Underweight by JP Morgan, from 9:52AM ET on Tuesday Nov 26, 2024 by Dow Jones
  9:52AM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: MRNA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 26, 2024 09:52 ET (14:52 GMT)
- JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating, from 5:35AM ET on Tuesday Nov 26, 2024 by MT Newswires
  5:35AM ET on Tuesday Nov 26, 2024 by MT Newswires
  Companies Mentioned: MRNA
  05:35 AM EST, 11/26/2024 (MT Newswires) -- Moderna (MRNA) has an average rating of hold and mean price target of $74.55, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and resea...
Nov 25, 2024
- RBC Cuts Price Target on Moderna to $50 From $62, Maintains Sector Perform Rating, from 7:05AM ET on Monday Nov 25, 2024 by MT Newswires
  7:05AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: MRNA
  07:05 AM EST, 11/25/2024 (MT Newswires) -- Moderna (MRNA) has an average rating of hold and mean price target of $74.55, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and resea...

Today
- Incyte Late-Breaking Tafasitamab (Monjuvi(R)) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma, from 8 minutes ago by Dow Jones
  8 minutes ago by Dow Jones
  Companies Mentioned: INCY
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON Public Limited Company (ICLR) and Encourages Stockholders to Learn More About the Investigation, from 34 minutes ago by Accesswire
  34 minutes ago by Accesswire
  Companies Mentioned: ICLR
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON Public Limited Company (ICLR) and Encourages Stockholders to Learn More About the Investigation, from 35 minutes ago by Dow Jones
  35 minutes ago by Dow Jones
  Companies Mentioned: ICLR
- DJ Biogen Price Target Announced at $178.00/Share by B of A Securities, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: BIIB
- INCY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Incyte Corporation, from 3 hours ago by Accesswire
  3 hours ago by Accesswire
  Companies Mentioned: INCY
- INCY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Incyte Corporation, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: INCY
Yesterday
- Bronstein, Gewirtz & Grossman, LLC Encourages ICON Public Limited Company (ICLR) Investors to Inquire about Securities Investigation, from 10:01AM ET on Monday Dec 09, 2024 by Accesswire
  10:01AM ET on Monday Dec 09, 2024 by Accesswire
  Companies Mentioned: ICLR
- Bronstein, Gewirtz & Grossman, LLC Encourages ICON Public Limited Company (ICLR) Investors to Inquire about Securities Investigation, from 10:01AM ET on Monday Dec 09, 2024 by Dow Jones
  10:01AM ET on Monday Dec 09, 2024 by Dow Jones
  Companies Mentioned: ICLR
- Levi & Korsinsky Reminds Incyte Corporation Investors of the Ongoing Investigation into Potential Violations of Securities Laws - INCY, from 7:28AM ET on Monday Dec 09, 2024 by Accesswire
  7:28AM ET on Monday Dec 09, 2024 by Accesswire
  Companies Mentioned: INCY
- Levi & Korsinsky Reminds Incyte Corporation Investors of the Ongoing Investigation into Potential Violations of Securities Laws - INCY, from 7:28AM ET on Monday Dec 09, 2024 by Dow Jones
  7:28AM ET on Monday Dec 09, 2024 by Dow Jones
  Companies Mentioned: INCY

Moderna Inc
NASDAQ:MRNAUnited States

Search Criteria

Today

DJ Moderna Price Target Announced at $41.00/Share by B of A Securities, from 2 hours ago by Dow Jones

Dec 3, 2024

DexCom, Orthofix, Spire Global, and Moderna Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information, from 8:07AM ET on Tuesday Dec 03, 2024 by Dow Jones

Nov 26, 2024

DJ Moderna Is Maintained at Underweight by JP Morgan, from 9:52AM ET on Tuesday Nov 26, 2024 by Dow Jones

JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating, from 5:35AM ET on Tuesday Nov 26, 2024 by MT Newswires

Nov 25, 2024

RBC Cuts Price Target on Moderna to $50 From $62, Maintains Sector Perform Rating, from 7:05AM ET on Monday Nov 25, 2024 by MT Newswires

Peers Headlines

Today

Incyte Late-Breaking Tafasitamab (Monjuvi(R)) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma, from 8 minutes ago by Dow Jones

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON Public Limited Company (ICLR) and Encourages Stockholders to Learn More About the Investigation, from 34 minutes ago by Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICON Public Limited Company (ICLR) and Encourages Stockholders to Learn More About the Investigation, from 35 minutes ago by Dow Jones

DJ Biogen Price Target Announced at $178.00/Share by B of A Securities, from 2 hours ago by Dow Jones

INCY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Incyte Corporation, from 3 hours ago by Accesswire

INCY ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Incyte Corporation, from 3 hours ago by Dow Jones

Yesterday

Bronstein, Gewirtz & Grossman, LLC Encourages ICON Public Limited Company (ICLR) Investors to Inquire about Securities Investigation, from 10:01AM ET on Monday Dec 09, 2024 by Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages ICON Public Limited Company (ICLR) Investors to Inquire about Securities Investigation, from 10:01AM ET on Monday Dec 09, 2024 by Dow Jones

Levi & Korsinsky Reminds Incyte Corporation Investors of the Ongoing Investigation into Potential Violations of Securities Laws - INCY, from 7:28AM ET on Monday Dec 09, 2024 by Accesswire

Levi & Korsinsky Reminds Incyte Corporation Investors of the Ongoing Investigation into Potential Violations of Securities Laws - INCY, from 7:28AM ET on Monday Dec 09, 2024 by Dow Jones